Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health Dashboard.
Saved in:
| Title: | Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health Dashboard. |
|---|---|
| Authors: | Shirke, Avanti V.1, Radke, Elizabeth G.1, Lin, Cynthia2, Blain, Robyn2, Vetter, Nicole2, Lemeris, Courtney2, Hartman, Pamela2, Hubbard, Heidi2, Angrish, Michelle3, Arzuaga, Xabier1, Congleton, Johanna1, Davis, Allen1, Dishaw, Laura V.3, Jones, Ryan4, Judson, Richard5, Kaiser, J. Phillip6, Kraft, Andrew1, Lizarraga, Lucina6, Noyes, Pamela D.1, Patlewicz, Grace5 |
| Source: | Environmental Health Perspectives. Feb2024, Vol. 132 Issue 2, p026001-1-026001-24. 24p. |
| Subject Terms: | *Environmental monitoring, *Mammals, *Pollutants, *Fluorocarbons, Dashboards (Management information systems), Risk assessment, Health status indicators, Grey literature, Immune system, Internet, Metadata, Evidence-based medicine, Sulfur acids, Biological assay |
| Geographic Terms: | United States |
| Company/Entity: | United States. Environmental Protection Agency |
| Abstract: | BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) encompass a class of chemically and structurally diverse compounds that are extensively used in industry and detected in the environment. The US Environmental Protection Agency (US EPA) 2021 PFAS Strategic Roadmap describes national research plans to address the challenge of PFAS. OBJECTIVES: Systematic Evidence Map (SEM) methods were used to survey and summarize available epidemiological and mammalian bioassay evidence that could inform human health hazard identification for a set of 345 PFAS that were identified by the US EPA’s Center for Computational Toxicology and Exposure (CCTE) for in vitro toxicity and toxicokinetic assay testing and through interagency discussions on PFAS of interest. This work builds from the 2022 evidence map that collated evidence on a separate set of ~150 PFAS. Like our previous work, this SEM does not include PFAS that are the subject of ongoing or completed assessments at the US EPA. METHODS: SEM methods were used to search, screen, and inventory mammalian bioassay and epidemiological literature from peer-reviewed and gray literature sources using manual review and machine-learning software. For each included study, study design details and health end points examined were summarized in interactive web-based literature inventories. Some included studies also underwent study evaluation and detailed extraction of health end point data. All underlying data is publicly available online as interactive visuals with downloadable metadata. RESULTS: More than 13,000 studies were identified from scientific databases. Screening processes identified 121 mammalian bioassay and 111 epidemiological studies that met screening criteria. Epidemiological evidence (available for 12 PFAS) mostly assessed the reproductive, endocrine, developmental, metabolic, cardiovascular, and immune systems. Mammalian bioassay evidence (available for 30 PFAS) commonly assessed effects in the reproductive, whole-body, nervous, and hepatic systems. Overall, 41 PFAS had evidence across mammalian bioassay and epidemiology data streams (roughly 11% of searched chemicals). DISCUSSION: No epidemiological and/or mammalian bioassay evidence were identified for most of the PFAS included in our search. Results from this SEM, our 2022 SEM on ~150 PFAS, and other PFAS assessment products from the US EPA are compiled into a comprehensive PFAS dashboard that provides researchers and regulators an overview of the current PFAS human health landscape including data gaps and can serve as a scoping tool to facilitate prioritization of PFAS-related research and/or risk assessment activities. [ABSTRACT FROM AUTHOR] |
| Copyright of Environmental Health Perspectives is the property of National Institute of Environmental Health Sciences and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | GreenFILE |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: 8gh DbLabel: GreenFILE An: 175957099 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health Dashboard. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Shirke%2C+Avanti+V%2E%22">Shirke, Avanti V.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Radke%2C+Elizabeth+G%2E%22">Radke, Elizabeth G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lin%2C+Cynthia%22">Lin, Cynthia</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Blain%2C+Robyn%22">Blain, Robyn</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Vetter%2C+Nicole%22">Vetter, Nicole</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Lemeris%2C+Courtney%22">Lemeris, Courtney</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Hartman%2C+Pamela%22">Hartman, Pamela</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Hubbard%2C+Heidi%22">Hubbard, Heidi</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Angrish%2C+Michelle%22">Angrish, Michelle</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Arzuaga%2C+Xabier%22">Arzuaga, Xabier</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Congleton%2C+Johanna%22">Congleton, Johanna</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Davis%2C+Allen%22">Davis, Allen</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dishaw%2C+Laura+V%2E%22">Dishaw, Laura V.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Jones%2C+Ryan%22">Jones, Ryan</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Judson%2C+Richard%22">Judson, Richard</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Kaiser%2C+J%2E+Phillip%22">Kaiser, J. Phillip</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Kraft%2C+Andrew%22">Kraft, Andrew</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lizarraga%2C+Lucina%22">Lizarraga, Lucina</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Noyes%2C+Pamela+D%2E%22">Noyes, Pamela D.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Patlewicz%2C+Grace%22">Patlewicz, Grace</searchLink><relatesTo>5</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Environmental+Health+Perspectives%22">Environmental Health Perspectives</searchLink>. Feb2024, Vol. 132 Issue 2, p026001-1-026001-24. 24p. – Name: Subject Label: Subject Terms Group: Su Data: *<searchLink fieldCode="DE" term="%22Environmental+monitoring%22">Environmental monitoring</searchLink><br />*<searchLink fieldCode="DE" term="%22Mammals%22">Mammals</searchLink><br />*<searchLink fieldCode="DE" term="%22Pollutants%22">Pollutants</searchLink><br />*<searchLink fieldCode="DE" term="%22Fluorocarbons%22">Fluorocarbons</searchLink><br /><searchLink fieldCode="DE" term="%22Dashboards+%28Management+information+systems%29%22">Dashboards (Management information systems)</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+assessment%22">Risk assessment</searchLink><br /><searchLink fieldCode="DE" term="%22Health+status+indicators%22">Health status indicators</searchLink><br /><searchLink fieldCode="DE" term="%22Grey+literature%22">Grey literature</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+system%22">Immune system</searchLink><br /><searchLink fieldCode="DE" term="%22Internet%22">Internet</searchLink><br /><searchLink fieldCode="DE" term="%22Metadata%22">Metadata</searchLink><br /><searchLink fieldCode="DE" term="%22Evidence-based+medicine%22">Evidence-based medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Sulfur+acids%22">Sulfur acids</searchLink><br /><searchLink fieldCode="DE" term="%22Biological+assay%22">Biological assay</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink> – Name: SubjectCompany Label: Company/Entity Group: Su Data: <searchLink fieldCode="DE" term="%22United+States%2E+Environmental+Protection+Agency%22">United States. Environmental Protection Agency</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) encompass a class of chemically and structurally diverse compounds that are extensively used in industry and detected in the environment. The US Environmental Protection Agency (US EPA) 2021 PFAS Strategic Roadmap describes national research plans to address the challenge of PFAS. OBJECTIVES: Systematic Evidence Map (SEM) methods were used to survey and summarize available epidemiological and mammalian bioassay evidence that could inform human health hazard identification for a set of 345 PFAS that were identified by the US EPA’s Center for Computational Toxicology and Exposure (CCTE) for in vitro toxicity and toxicokinetic assay testing and through interagency discussions on PFAS of interest. This work builds from the 2022 evidence map that collated evidence on a separate set of ~150 PFAS. Like our previous work, this SEM does not include PFAS that are the subject of ongoing or completed assessments at the US EPA. METHODS: SEM methods were used to search, screen, and inventory mammalian bioassay and epidemiological literature from peer-reviewed and gray literature sources using manual review and machine-learning software. For each included study, study design details and health end points examined were summarized in interactive web-based literature inventories. Some included studies also underwent study evaluation and detailed extraction of health end point data. All underlying data is publicly available online as interactive visuals with downloadable metadata. RESULTS: More than 13,000 studies were identified from scientific databases. Screening processes identified 121 mammalian bioassay and 111 epidemiological studies that met screening criteria. Epidemiological evidence (available for 12 PFAS) mostly assessed the reproductive, endocrine, developmental, metabolic, cardiovascular, and immune systems. Mammalian bioassay evidence (available for 30 PFAS) commonly assessed effects in the reproductive, whole-body, nervous, and hepatic systems. Overall, 41 PFAS had evidence across mammalian bioassay and epidemiology data streams (roughly 11% of searched chemicals). DISCUSSION: No epidemiological and/or mammalian bioassay evidence were identified for most of the PFAS included in our search. Results from this SEM, our 2022 SEM on ~150 PFAS, and other PFAS assessment products from the US EPA are compiled into a comprehensive PFAS dashboard that provides researchers and regulators an overview of the current PFAS human health landscape including data gaps and can serve as a scoping tool to facilitate prioritization of PFAS-related research and/or risk assessment activities. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Environmental Health Perspectives is the property of National Institute of Environmental Health Sciences and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=8gh&AN=175957099 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1289/EHP13423 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 24 StartPage: 026001-1 Subjects: – SubjectFull: Environmental monitoring Type: general – SubjectFull: Mammals Type: general – SubjectFull: Pollutants Type: general – SubjectFull: Fluorocarbons Type: general – SubjectFull: Dashboards (Management information systems) Type: general – SubjectFull: Risk assessment Type: general – SubjectFull: Health status indicators Type: general – SubjectFull: Grey literature Type: general – SubjectFull: Immune system Type: general – SubjectFull: Internet Type: general – SubjectFull: Metadata Type: general – SubjectFull: Evidence-based medicine Type: general – SubjectFull: Sulfur acids Type: general – SubjectFull: Biological assay Type: general – SubjectFull: United States Type: general – SubjectFull: United States. Environmental Protection Agency Type: general Titles: – TitleFull: Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health Dashboard. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shirke, Avanti V. – PersonEntity: Name: NameFull: Radke, Elizabeth G. – PersonEntity: Name: NameFull: Lin, Cynthia – PersonEntity: Name: NameFull: Blain, Robyn – PersonEntity: Name: NameFull: Vetter, Nicole – PersonEntity: Name: NameFull: Lemeris, Courtney – PersonEntity: Name: NameFull: Hartman, Pamela – PersonEntity: Name: NameFull: Hubbard, Heidi – PersonEntity: Name: NameFull: Angrish, Michelle – PersonEntity: Name: NameFull: Arzuaga, Xabier – PersonEntity: Name: NameFull: Congleton, Johanna – PersonEntity: Name: NameFull: Davis, Allen – PersonEntity: Name: NameFull: Dishaw, Laura V. – PersonEntity: Name: NameFull: Jones, Ryan – PersonEntity: Name: NameFull: Judson, Richard – PersonEntity: Name: NameFull: Kaiser, J. Phillip – PersonEntity: Name: NameFull: Kraft, Andrew – PersonEntity: Name: NameFull: Lizarraga, Lucina – PersonEntity: Name: NameFull: Noyes, Pamela D. – PersonEntity: Name: NameFull: Patlewicz, Grace IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 00916765 Numbering: – Type: volume Value: 132 – Type: issue Value: 2 Titles: – TitleFull: Environmental Health Perspectives Type: main |
| ResultId | 1 |